What Obama’s Plan for ‘Precision Medicine’ Really Means

The president wants to help develop new, more effective drugs.

Prescription Medicine
National Journal
Sam Baker
Add to Briefcase
See more stories about...
Sam Baker
Jan. 20, 2015, 4:12 p.m.

Pres­id­ent Obama used his State of the Uni­on ad­dress Tues­day to launch a new ini­ti­at­ive that would use the hu­man gen­ome to build bet­ter med­ic­al treat­ments.

Obama called it the “Pre­ci­sion Medi­cine Ini­ti­at­ive” — so what’s pre­ci­sion medi­cine, any­way?

In short, it’s one of the most prom­ising and ex­cit­ing fields of med­ic­al re­search. Pre­ci­sion medi­cine, also known as “per­son­al­ized medi­cine,” is about the know­ledge we’ve gained by se­quen­cing the hu­man gen­ome. It’s the ef­fort to turn that know­ledge in­to bet­ter, more ef­fect­ive medi­cines.

“I want the coun­try that elim­in­ated polio and mapped the hu­man gen­ome to lead a new era of medi­cine — one that de­liv­ers the right treat­ment at the right time,” Obama said. “In some pa­tients with cyst­ic fibrosis, this ap­proach has re­versed a dis­ease once thought un­stop­pable.”

The ap­proach is built largely on sci­ence’s im­proved un­der­stand­ing of ge­net­ics. The think­ing, roughly, is that doc­tors will be able to look to pa­tients’ genes to see wheth­er they’re at in­creased risk for cer­tain con­di­tions — mean­ing doc­tors could try to to pre­vent those dis­eases from de­vel­op­ing, or be on the lookout to treat them early if they do de­vel­op.

And by bet­ter un­der­stand­ing each pa­tient’s in­di­vidu­al ill­ness, doc­tors can bet­ter tail­or the right dose of the right medi­cine, at the right time.

Fran­cis Collins, the dir­ect­or of the Na­tion­al In­sti­tutes of Health, is a lead­ing ad­voc­ate for more per­son­al­ized medi­cine. Here’s how he de­scribed it in an in­ter­view last fall:

“If I got a dia­gnos­is of can­cer today, I would want that can­cer to be com­pletely se­quenced, to see what muta­tions are there that are driv­ing those cells to grow when they shouldn’t, and then to be able to use that in­form­a­tion to pick from the cur­rent menu — which is grow­ing rap­idly — of mo­lecu­larly tar­geted drugs.”

Es­pe­cially in terms of ac­tu­ally de­vel­op­ing medi­cines, it’s still a young field. Sci­ent­ists are learn­ing a lot, very quickly, about the un­der­ly­ing ge­net­ic causes of many dis­eases. But the busi­ness of trans­lat­ing that know­ledge in­to more tar­geted treat­ments is still just get­ting star­ted.

That’s what Obama pro­posed jump-start­ing in the State of the Uni­on.

“To­night, I’m launch­ing a new Pre­ci­sion Medi­cine Ini­ti­at­ive to bring us closer to cur­ing dis­eases like can­cer and dia­betes — and to give all of us ac­cess to the per­son­al­ized in­form­a­tion we need to keep ourselves and our fam­il­ies health­i­er,” he planned to say, ac­cord­ing to the pre­pared speech.

He might even be able to find some bi­par­tis­an sup­port, de­pend­ing on the de­tails of the plan. (The pre­pared text didn’t of­fer any more in­form­a­tion.)

The House En­ergy and Com­merce Com­mit­tee, chaired by Rep. Fred Up­ton, is in the midst of an am­bi­tious pro­ject to fig­ure out a bet­ter way to test and ap­prove new drugs. Ahead of Tues­day’s speech, Up­ton praised the co­oper­a­tion he has re­ceived from top Health and Hu­man Ser­vices of­fi­cials, in­clud­ing Sec­ret­ary Sylvia Math­ews Bur­well.

Up­ton’s and Obama’s ini­ti­at­ives aren’t the same — Up­ton’s is about the reg­u­la­tion of new drugs, while the pres­id­ent’s is about their de­vel­op­ment. But, of course, those two things go hand in hand.

What We're Following See More »
$618 BILLION IN FUNDING
By a Big Margin, House Passes Defense Bill
1 days ago
THE DETAILS

The National Defense Authorization Act passed the House this morning by a 375-34 vote. The bill, which heads to the Senate next week for final consideration, would fund the military to the tune of $618.7 billion, "about $3.2 billion more than the president requested for fiscal 2017. ... The White House has issued a veto threat on both the House and Senate-passed versions of the bill, but has not yet said if it will sign the compromise bill released by the conference committee this week."

Source:
SUCCEEDS UPTON
Walden to Chair Energy and Commerce Committee
1 days ago
THE DETAILS

"Republicans have elected Rep. Greg Walden (R-OR) the next chairman of the powerful House Energy and Commerce Committee. Walden defeated Reps. John Shimkus (R-IL) and Joe Barton (R-TX), the former committee chairman, in the race for the gavel" to succeed Michgan's Fred Upton.

Source:
BIPARTISAN SUPPORT
Senators Looking to Limit Deportations Under Trump
2 days ago
THE DETAILS

"Democratic and Republican members of the Senate Judiciary Committee are working on legislation that would limit deportations" under President-elect Donald Trump. Leading the effort are Judiciary Committee members Dick Durbin (D-IL) and Lindsey Graham (R-SC). Sen. Jeff Flake (R-AZ) is also expected to sign on.

Source:
REQUIRES CHANGE IN LAW
Trump Taps Mattis for Defense Secretary
2 days ago
BREAKING

Donald Trump has selected retired Marine Gen. James 'Mad Dog' Mattis as his secretary of defense, according to The Washington Post. Mattis retired from active duty just four years ago, so Congress will have "to pass new legislation to bypass a federal law that states secretaries of defense must not have been on active duty in the previous seven years." The official announcement is likely to come next week.

Source:
MEASURE HEADED TO OBAMA
Senate OKs 10-Year Extension of Iran Sanctions
2 days ago
THE LATEST
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login